← Scroll for more →
Financial Statements — TMTS
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 |
|---|---|---|---|
| Cash & Equivalents | 1.12 | 0.95 | -- |
| Total Current Assets | 1.24 | 1.03 | -- |
| Total Non-current Assets* | 232.84 | 231.11 | -- |
| Total Assets | 234.07 | 232.14 | 0.19 |
| Accounts Payable | 0.05 | 0.03 | 0.01 |
| Short-term Debt | 0.30 | 0.30 | 0.30 |
| Total Current Liabilities | 0.12 | 0.11 | 0.22 |
| Total Non-current Liabilities* | 2.30 | 2.30 | 0.00 |
| Total Liabilities | 2.42 | 2.41 | 0.22 |
| Retained Earnings | (1.15) | (1.03) | (1.04) |
| Total Stockholder Equity | (1.14) | (1.03) | (0.03) |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD)| Metric | Q2 2026 | Q1 2026 |
|---|---|---|
| Selling, General & Admin | 0.12 | 0.15 |
| Operating Income | (0.12) | (0.15) |
| Net Income | 1.93 | 0.90 |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 | Q1 2026 |
|---|---|---|
| Operating Cash Flow | (0.12) | (0.26) |
| Investing Cash Flow | 0.30 | (230.00) |
| Financing Cash Flow | (0.01) | 231.21 |
← Scroll for more columns →